Does scopolamine improve attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2011
INTERVENTION: A single dose of scopolamine (0.8mg contained in one capsule) (1‐2 week washout between conditions) CONDITION: Normal attention and cognitive functioning PRIMARY OUTCOME: Attentional processing measured using an EEF paradigm quantifying Steady State Visual Evoked Potentials Spatial attention using a Contingent Capture task SECONDARY OUTCOME: Nil INCLUSION CRITERIA: Healthy volunteers Aged 18‐40 years Male
Epistemonikos ID: 0a6c8743452df64d35b424645022de633476d596
First added on: Aug 25, 2024